EU Clears Prodesse’s H1N1 Test | GenomeWeb

NEW YORK (GenomeWeb News) – Prodesse’s molecular diagnostic test for H1N1 swine flu infections has been cleared by EU regulators for commercialization in Europe.

The firm, which recently became a subsidiary of Gen-Probe, received the CE Mark clearance for its ProFlu-ST assay as a diagnostic to differentiate among influenza strains.

The RT-PCR-based test detects and identifies the 2009 H1N1 virus, the seasonal influenza A/H1 virus, and the seasonal A/H3 virus.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: proteomic consequences of genomic changes in ovarian cancer, Human SRMAtlas, and more.

At Nature, John Wilbanks and Eric Topol call for openness in health data.

Law.com predicts that genomic and genetic testing will become common in toxic tort cases.

A Pew Research Center report finds that most Americans are wary of using technologies like gene editing to enhance human abilities.